Clinical Trial Update: An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix

View source ↗

Summary

A multicenter anterior cervical discectomy and fusion trial using ViviGen Cellular Bone Matrix sponsored by DePuy Spine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spondylosis
• Degenerative Disc Disease
• Herniated Disc

Drugs mentioned

• ViviGen Cellular Bone Matrix (cellular bone matrix)

Snippet

Sponsor: DePuy Spine | Conditions: Cervical Spondylosis, Degenerative Intervertebral Discs | Status: COMPLETED